National Institute on Aging; Notice of Closed Meetings, 1815 [2020-00269]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 8 / Monday, January 13, 2020 / Notices
Date: March 4, 2020.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Xinli Nan, M.D., Ph.D.,
Scientific Review Officer, Division of
Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892,
(301) 594–7784, Xinli.Nan@nih.gov.
Name of Committee: National Institute on
Minority Health and Health Disparities
Special Emphasis Panel; Specialized Centers
of Excellence on Environmental Health
Disparities Research (P50 Clinical Trial
Optional).
Date: March 10–12, 2020.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Holiday Inn Gaithersburg, Walker
Conference Room and Whetstone Conference
Room 2, Montgomery Village Avenue,
Gaithersburg, MD 20879.
Contact Person: Maryline Laude-Sharp,
Ph.D., Scientific Review Officer, Division of
Scientific Programs, National Institutes of
Health, NIMHD, Gateway Building, 7201
Wisconsin Avenue, Ste. 525, MSC. 9206,
Bethesda, MD 20892, (301) 451–9536,
mlaudesharp@mail.nih.gov.
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00273 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
National Center for Advancing
Translational Sciences; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Advancing Translational Sciences Special
Emphasis Panel; NTU.
Date: February 5, 2020.
VerDate Sep<11>2014
16:32 Jan 10, 2020
Jkt 250001
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, DEM1,
6701 Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Barbara J. Nelson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Center for Advancing
Translational Sciences (NCATS), National
Institutes of Health, 6701 Democracy Blvd.,
Democracy 1, Room 1080, Bethesda, MD
20892–4874, 301–435–0806, nelsonbj@
mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: January 7, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00268 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Drug
Repositioning and Combination Therapy for
AD.
Date: February 11, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
PO 00000
Frm 00016
Fmt 4703
Sfmt 4703
1815
Name of Committee: National Institute on
Aging Special Emphasis Panel; Pepper Center
Review.
Date: February 19–20, 2020.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda,
Conference Room, Bethesda Chevy Chase,
7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Anita H. Undale, MD,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building, Suite 2W200, 7201 Wisconsin
Avenue, Bethesda, MD 20892, (301) 827–
7428, anita.undale@nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; Alzheimer’s
Disease Drug Development.
Date: February 19, 2020.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Telephone Conference
Call).
Contact Person: Alexander Parsadanian,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2C/212, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–9666,
parsadaniana@nia.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–00269 Filed 1–10–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\13JAN1.SGM
13JAN1
]]>Agencies
[Federal Register Volume 85, Number 8 (Monday, January 13, 2020)]
[Notices]
[Page 1815]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-00269]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Aging Special Emphasis
Panel; Drug Repositioning and Combination Therapy for AD.
Date: February 11, 2020.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Parsadanian, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892, (301) 496-9666,
[email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; Pepper Center Review.
Date: February 19-20, 2020.
Time: 3:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, Conference Room, Bethesda
Chevy Chase, 7301 Waverly Street, Bethesda, MD 20814.
Contact Person: Anita H. Undale, MD, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Building, Suite 2W200, 7201
Wisconsin Avenue, Bethesda, MD 20892, (301) 827-7428,
[email protected].
Name of Committee: National Institute on Aging Special Emphasis
Panel; Alzheimer's Disease Drug Development.
Date: February 19, 2020.
Time: 12:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute on Aging, Gateway Building, 7201
Wisconsin Avenue, Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Parsadanian, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Building 2C/212, 7201
Wisconsin Avenue, Bethesda, MD 20892, (301) 496-9666,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging
Research, National Institutes of Health, HHS)
Dated: January 7, 2020.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-00269 Filed 1-10-20; 8:45 am]
BILLING CODE 4140-01-P
